AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

February 16, 2022

Period of Report

February 10, 2022

Accession Number

0001096906-22-000353

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →